Pharmaceuticals, Biotechnology and Life Sciences
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that a Phase 3 monotherapy study met its primary endpoint demonstrating that sarilumab…
Sanofi welcomes new Executive Committee member
Sanofi and MSD/Merck in joint vaccines operations in Europe
Premaitha signs distribution agreement with GeNext in Russia
One of India’s best-known whistleblowers, who exposed dangerous practices in the generic drug industry in 2013, is taking the country’s drugs regulators to court, accusing them of failing to enforce rules on drug safety in the $15 billion (11 billion pound) industry.
AstraZeneca and MedImmune, its global biologics research and development arm, on Wednesday announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) for durvalumab (MEDI4736), an investigational human monoclonal antibody directed against programmed death ligand-1 (PD-L1), for the treatment of patients with PD-L1 positive inoperable or metastatic urothelial bladder cancer whose tumour has progressed during or after one standard platinum-based regimen.
Premaitha Health, the developer of IONA test, has partnered with Leeds Teaching Hospitals NHS Trust to provide a private NIPT…
Glenmark Pharmaceuticals entering $130M market with Actavis’ Potassium Cholire capsules and generics of Warner Chilcott’s Loestrin tablets
Indian pharmaceutical company Natco Pharma Limited has signed a nonexclusive, royalty free licensing agreement with the Medicines Patent Pool and…
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has decided to cancel the admission of its ordinary shares to trading…